YahooSeptember 29, 2026 at 9:12 AM NY28 Days Ago
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now
RVTY's diagnostics growth, AI-driven demand and life sciences expansion support its outlook, though China and margin pressures pose near-term challenges.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
